Justin Stebbing to Therapeutic Equivalency
This is a "connection" page, showing publications Justin Stebbing has written about Therapeutic Equivalency.
Connection Strength
0.044
-
A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab. Cancer Chemother Pharmacol. 2018 03; 81(3):505-514.
Score: 0.044
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.